Radiopharmaceuticals for Sentinel Lymph Node Detection: Status and Trends

IAEA Radioisotopes and Radiopharmaceuticals Series No. 6

Subject Classification: 0200-Food and Agriculture

English STI/PUB/1674; (ISBN:978-92-0-109714-9); 162 pp.; 43 figures; € 39.00; Date Published: 2015

Download PDF (2.43 MB)

This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA coordinated research project.

IAEA Radioisotopes and Radiopharmaceuticals, Radioactive Tracers, Lymph Nodes, Cancer, Diagnostic Radiopharmaceuticals, Sentinel Lymph Node Detection, SLND, Biopsy, SLNB, Mammary Glands, Melanomas, Lymphatic System

Download Order Form PDF
You might also like

Quality Control in the Production of Radiopharmaceuticals ...




Read more

Good Practice for Introducing Radiopharmaceuticals for Clinical Use ...




Read more